Challenges in assessing statin-associated adverse events – Authors’ reply

Key Points

• Address the difficulties in accurately assessing adverse events associated with statin use.
• Discussed challenges faced in current assessment methods for statin-related adverse events.
• Reviewed existing clinical guidelines and pharmacovigilance practices.
• Provided insights into patient-reported outcomes and their significance.
• Identified gaps in current adverse event reporting of statin therapies.
• Proposed improvements for better understanding of statin-related side effects.
• Highlighted the need for updated clinical guidelines to enhance safety monitoring.